cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
about
Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitorsInteraction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finCloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitorHuman monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitorDistal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteasesCyclic nucleotide regulation of type-1 plasminogen activator-inhibitor mRNA stability in rat hepatoma cells. Identification of cis-acting sequencesThe anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesiclesAccessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitorHuman L1 retrotransposition: cis preference versus trans complementationFamilial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7.The 29-kDa proteins phosphorylated in thrombin-activated human platelets are forms of the estrogen receptor-related 27-kDa heat shock protein.Genetic markers on chromosome 7.Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbitsPlasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosisPurification, cDNA cloning, and characterization of a new serpin with megakaryocyte maturation activity.The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expressionBleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide.Post-transcriptional regulation of gene expression in the plasminogen activation system.Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma.Impact of the -675 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene on childhood IgA nephropathy.Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils.Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue.Identification of tissue-type plasminogen activator-specific plasminogen activator inhibitor-1 mutants. Evidence that second sites of interaction contribute to target specificity.Diverse gene sequences are overexpressed in werner syndrome fibroblasts undergoing premature replicative senescence.Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells.Genetic background of idiopathic pulmonary fibrosis.Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular DiseasePlasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence.Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.Tryptophan properties in fluorescence and functional stability of plasminogen activator inhibitor 1.Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 hnRNA.RFLP for Sst I (Sac I) at the human plasminogen activator inhibitor type 1 (PAI-1) gene locus.Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications.The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene.Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury.Recombinant Semliki Forest virus enhanced plasminogen activator inhibitor 1 expression and storage in the megakaryocytic cell line MEG-01.Apical and non-polarized secretion of serpins from MDCK cells.Ligand-toxin hybrids directed to the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein exhibit lower toxicity than native Pseudomonas exotoxin.
P2860
Q24297884-A1760CF7-B6F6-46A9-BE58-EF7B6BB1C927Q24300911-287F2D33-1A23-420B-83F8-09229310FB70Q24655336-E6B82035-34A6-4E11-8EBB-1D9E5C16B4C0Q24682654-E9A31415-C706-4C49-90A1-45BD7FFA29A1Q24793473-EA0B07AC-C7D3-4BDB-98A6-3E2C4803500EQ28569540-889EE155-E50C-4017-87C4-990CDE8A87A5Q28579043-6E72C079-BFA0-4825-B071-A1F47A437269Q28647054-69147F1D-9729-4963-B42E-47F61B6D16ABQ29618363-946E6C2F-9029-47DF-B44B-CB48F1B4C2CFQ30501518-74ED85E8-45F1-4CBF-A832-39B70C4361CCQ33290796-C345333D-9011-42FF-AA4F-F045EC2C0871Q33676661-FE2ECDB8-6F58-420D-B3E1-763D62FE2E42Q33848439-AA8FA999-DC2C-45AB-ABD0-A6607A13620DQ34372572-3832BE45-3FBC-425B-99AD-9D8A2AAF3F97Q34428667-B8340482-5D24-4CC9-83D5-09AC060F5853Q34559926-39F28C79-08FF-4C70-A494-CA0572FCA32BQ34573519-1FB207EE-0DE9-4BFE-B78B-1225D7333FFAQ34576333-C7F6042C-0E34-40FA-A6E2-DF715AB809DDQ34584801-2FDF8831-3DDC-4D20-A23B-AAC12361EF3EQ34774748-8D0ED0B4-B507-4DEA-B406-664A78E1671FQ35816808-364A633E-8DF0-42E8-B919-B39EF7A17AAAQ36224280-FA7749D7-FCB4-433D-B4CA-DC3EFA5A9C0DQ36356179-FC27F312-F0D6-4E00-9508-F4E1B7CDEB3EQ36695468-37E7141C-A77C-42ED-89EC-F78EAA977F64Q36700767-A523E3C7-557D-4E45-8A09-76E3639ED29BQ36727404-429F8C4E-BC5F-4AE1-A368-3868D74B5741Q36920255-849146C6-AB33-4FB7-B0F6-FFA87C66718BQ38103596-8ED3261A-3332-4556-9E24-B4D7F215C1D7Q38128321-D2579DF9-4F91-4C09-B77C-35CD884F2952Q39344951-86F97254-972D-4D6D-8236-010F3470462DQ39508019-030E96D7-CB88-4A66-A9E6-25F8CEB1A86BQ40243697-E0664EF7-E2FF-48A8-8DDC-1CD7C5C78CC6Q40406056-E1B7ED37-C903-41E2-8D8E-EF00CEA390FEQ40448345-27F643FE-80C5-4C99-AAF9-FA58DC4C5B83Q40475372-1F631F19-11F0-4CF4-B3E6-B6007A35B4D6Q40545045-6F0F2E3A-7F49-449D-BFFE-FA7FE8FE4F44Q40757687-77E0C781-9F60-4B41-9C5D-CDC7BBB95CD9Q40783138-63923CF1-A704-4A81-AE4B-A369A615EBEBQ40878809-08900346-4619-40BB-A1B0-0A67C26DA33FQ41216069-A67CC26B-7C9D-47C0-9359-41013B36D720
P2860
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
description
1986 nî lūn-bûn
@nan
1986 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
@ast
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
@en
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
@nl
type
label
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
@ast
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
@en
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
@nl
prefLabel
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
@ast
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
@en
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
@nl
P2093
P2860
P356
P1476
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
@en
P2093
D Ginsburg
P A Andreasen
T D Gelehrter
U M Rafferty
P2860
P304
P356
10.1172/JCI112761
P407
P577
1986-12-01T00:00:00Z